Publication

Article

BioPharm International

BioPharm International-10-01-2001
Volume14
Issue 10

Outsourcing Outlook

Author(s):

Jim Miller

by Jim Miller

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue
Qualification of Network Components and Validation of Networked Systems
Statistical Tools for Setting In-Process Acceptance Criteria
Managing Your Career: Recruiter-Proof Your Organization
Employing Murine MAbs as Ancillary Products in Cell Therapy Manufacturing: Part 1, Considerations for Technology Transfer and Commercial Development
Inside Washington: Crisis and Costs Grip Biotech Industry
Outsourcing Outlook

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, CSO, AustinPx
Related Content
Background with viruses. Adeno-associated virus serotype 1. Virus is used as a vector for gene therapy. A model is built using data of viral macromolecular structure from Protein Data Bank (PDB 3NG9) | Image credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
August 13th 2025

ProBio Launches End-to-End AAV Production at NJ Manufacturing Site

Feliza Mirasol
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 13th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Site Logo
August 13th 2025

Demand-Led Clinical Supply Model for Program-level Product Pooling in Global Decentralized Study

Mastering Antibody-Drug Conjugates
August 13th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Site Logo
August 13th 2025

European Clinical Supply Planning – Balancing Cost, Flexibility & Time

Site Logo
August 13th 2025

BIOVECTRA - Single-use Fermenters for the Production of Biologics

© 2025 MJH Life Sciences

All rights reserved.